Aptevo Therapeutics Inc. (APVO) Financials
APVO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 24.8 million | 12.6 million |
2023-09-30 | 27.1 million | 12.4 million |
2023-06-30 | 28.9 million | 12.7 million |
2023-03-31 | 35.0 million | 11.7 million |
APVO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -5.3 million | 358000 |
2023-09-30 | -6.2 million | 455000 |
2023-06-30 | -4.8 million | 465000 |
2023-03-31 | 4.6 million | 915000 |
APVO Net Income
No data available :(
APVO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 16.9 million | - | 5.4 million |
2023-09-30 | 19.1 million | - | 5.6 million |
2023-06-30 | 21.0 million | - | 5.7 million |
2023-03-31 | 25.3 million | - | 5.9 million |
APVO Shares Outstanding
APVO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 3.5 million | 2.8 million | - |
2023-09-30 | - | 3.9 million | 2.7 million | - |
2023-06-30 | - | 5.5 million | 2.7 million | - |
2023-03-31 | - | 4.2 million | 3.6 million | - |
APVO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 116000 |
2023-09-30 | - | 123000 |
2023-06-30 | - | 150000 |
2023-03-31 | - | 178000 |
APVO
Price: $0.96
52 week price:
Earnings Per Share: -67.07 USD
P/E Ratio: -0.06
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 73389
Ebitda: -9.5 millionMarket Capitalization: 2.5 million